Related Experiment Video
Updated: Feb 11, 2026

Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis
Published on: May 16, 2025
Programmable Biohybrid Probiotics with Long-Term Storage Stability for Enhanced Intestinal Microbiota Regulation and
Jiani Jiang1, Jiangyan Dong1, Zhouping Tian1
1Guangdong Engineering Research Center of Low-Carbon Synthetic Biotechnology, State Key Laboratory of Pulp and Paper Engineering, School of Biology and Biological Engineering, South China University of Technology, Guangzhou, P. R. China.
Abstract:
Ulcerative colitis (UC) is a chronic inflammatory bowel disease with limited therapeutic options and high relapse rates. Live bacterial therapeutics (LBTs) offer a promising alternative by restoring mucosal integrity, modulating immunity, and rebalancing gut microbiota; however, their clinical translation is constrained by poor storage stability, low gastrointestinal survivability, and limited therapeutic functionality. Here, we report a multilevel, modular encapsulation strategy that integrates a metal-polyphenol network (MPN) and silica-based shell with iron-based metal-organic framework (MIL-101(Fe)) nanocomponents to construct a biohybrid probiotic system (Bif@FCSM(A), where "A" denotes 5-aminosalicylic acid). This hierarchical assembly forms an oxygen-shielding, mechanically reinforced shell, resulting in a 41-fold improvement in aerobic storage stability and an 871-fold enhancement in gastric survivability of the anaerobe Bifidobacterium longum. Incorporation of MIL-101(Fe) enables high-capacity drug loading and inflammation-responsive disassembly via transferrin (Tf)-mediated Fe3 + chelation in inflamed colonic tissue, thereby achieving spatiotemporally controlled bacterial activation and drug release. Guided by UC transcriptomic signatures, this combinatorial design concurrently targets immune dysregulation and microbial imbalance. In a dextran sulfate sodium-induced murine UC model, Bif@FCSM(A) markedly alleviated disease severity, suppressed pro-inflammatory cytokines, restored mucosal immune homeostasis, and enriched short-chain fatty acid-producing taxa. This work establishes a programmable, pathology-responsive probiotic platform with translational potential for complex inflammatory diseases.
More Related Videos
08:34Investigating the Alleviating Effects of Bacillus cereus Administration on Colitis through Gut Microbiota Modulation
Published on: July 27, 2022
08:58Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
Related Concept Videos
Drugs for Treatment of Ulcerative Colitis in IBD
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Storage
RNA Stability
Epigenetic Regulation